FENIMORE CHRISTOPHER R. 1697422 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-25 | 2023-08-23 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 4269.0 | 0 | 0.4 | 0.0 | 2022 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 106.74 (REGN) | ||
| 2023-08-25 | 2023-08-23 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 1897.0 | 0 | 0.18 | 0.0 | By Trust | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 106.74 (REGN) | ||
| 2023-08-25 | 2023-08-23 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 1473.0 | 0 | 0.14 | 0.0 | 2021 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 106.74 (REGN) | ||
| 2023-08-25 | 2023-08-23 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 460.0 | 0 | 0.04 | 0.0 | By Trust For Son | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 106.74 (REGN) | ||
| 2023-08-25 | 2023-08-23 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 1499.0 | 0 | 0.14 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 106.74 (REGN) | ||
| 2023-08-25 | 2023-08-23 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 461.0 | 0 | 0.04 | 0.0 | By Trust For Daugh | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 106.74 (REGN) | ||
| 2023-08-25 | 2023-08-23 | 2023-08-23 | 4 | Fenimore Christopher R. | SVP CONTROLLER | dsp | 5198.0 | 19.89 | 0.49 | 842.66 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F | 20942.0 | 106.74 (REGN) |
| 2023-08-25 | 2023-08-23 | 2023-08-23 | 4 | Fenimore Christopher R. | SVP CONTROLLER | acq | 7000.0 | 26.78 | 0.66 | 399.66 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 26140.0 | 106.74 (REGN) |
| 2023-12-12 | 2023-12-08 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 1897.0 | 0 | 0.18 | 0.0 | By Trust | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-12 | 2023-12-08 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 460.0 | 0 | 0.04 | 0.0 | By Trust For Son | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-12 | 2023-12-08 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 1473.0 | 0 | 0.14 | 0.0 | 2021 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-12 | 2023-12-08 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 1499.0 | 0 | 0.14 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-12 | 2023-12-08 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 461.0 | 0 | 0.04 | 0.0 | By Trust For Daugh | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-12 | 2023-12-08 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 4269.0 | 0 | 0.4 | 0.0 | 2022 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-12 | 2023-12-08 | 2023-12-08 | 4 | Fenimore Christopher R. | SVP CONTROLLER | acq | 2370.0 | 10.38 | 0.22 | 0.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code A | 22838.0 | 107.13 (REGN) |
| 2023-12-12 | 2023-12-08 | 2023-12-08 to 2023-12-11 | 4 | Fenimore Christopher R. | SVP CONTROLLER | dsp | 2010.0 | 8.62 | 0.19 | 844.02 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F | 21302.0
|
107.13 (REGN) |
| 2023-12-14 | 2023-12-12 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 4269.0 | 0 | 0.4 | 0.0 | 2022 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-14 | 2023-12-12 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 461.0 | 0 | 0.04 | 0.0 | By Trust For Daugh | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-14 | 2023-12-12 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 1499.0 | 0 | 0.14 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-14 | 2023-12-12 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 1473.0 | 0 | 0.14 | 0.0 | 2021 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-14 | 2023-12-12 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 460.0 | 0 | 0.04 | 0.0 | By Trust For Son | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-14 | 2023-12-12 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 1897.0 | 0 | 0.18 | 0.0 | By Trust | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-14 | 2023-12-12 | 2023-12-12 | 4 | Fenimore Christopher R. | SVP CONTROLLER | dsp | 2552.0 | 11.98 | 0.24 | 856.71 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F | 18750.0 | 107.13 (REGN) |
| 2023-12-26 | 2023-12-21 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 1473.0 | 0 | 0.14 | 0.0 | 2021 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-26 | 2023-12-21 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 461.0 | 0 | 0.04 | 0.0 | By Trust For Daugh | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-26 | 2023-12-21 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 4269.0 | 0 | 0.4 | 0.0 | 2022 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-26 | 2023-12-21 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 1897.0 | 0 | 0.18 | 0.0 | By Trust | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-26 | 2023-12-21 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 1499.0 | 0 | 0.14 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-26 | 2023-12-21 | 4 | Fenimore Christopher R. | SVP CONTROLLER | holding | 460.0 | 0 | 0.04 | 0.0 | By Trust For Son | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-26 | 2023-12-21 | 2023-12-21 to 2023-12-22 | 4 | Fenimore Christopher R. | SVP CONTROLLER | dsp | 1930.0 | 10.29 | 0.18 | 844.3 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 16820.0
|
107.13 (REGN) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-25 | 2023-08-23 | 2023-08-23 | 4 | Fenimore Christopher R. | SVP CONTROLLER | dsp | 7000.0 | 41.18 | 0.66 | 399.66 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 10000.0 | 106.74 (REGN) |
| 2023-12-12 | 2023-12-08 | 2023-12-08 | 4 | Fenimore Christopher R. | SVP CONTROLLER | acq | 8499.0 | 100.0 | 0.79 | 843.79 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code A | 8499.0 | 107.13 (REGN) |
| 2024-01-04 | 2024-01-03 | 2024-01-03 | 4 | Fenimore Christopher R. | SVP CONTROLLER | dsp | 10000.0 | 66.67 | 0.93 | 477.67 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 5000.0
|
107.13 (REGN) |
| 2024-01-25 | 2024-01-23 | 2024-01-23 | 4 | Fenimore Christopher R. | SVP CONTROLLER | dsp | 10000.0 | 100.0 | 0.93 | 477.67 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 0.0
|
107.13 (REGN) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)